Cardiac health and regular cardiovascular screening is important to enable risk factors to be detected in their earliest stages. Randox reagents enable the risk assessment of cardiac events with key assays including sLDL Cholesterol, Lipoprotein(a), Homocysteine and hsCRP; early detection of a cardiac episode having taken place with use of our H-FABP assay; and, measurement of response to Aspirin therapy with use of our TxBCardio assay. In addition we manufacture a range of high performing and unique cardiology reagents to ensure vital detection is possible; these include Adiponectin, sPLA2-IIA, Apo C-II, Apo C-III and Apo E.
To discover more about our range of cardiology assays select an option from the drop-down menu. Alternatively, to gain an understanding of cardiovascular disease and the relevance of Randox cardiology assays please read the sections below.